Friend or Foe - Tc17 Cell Generation and Current Evidence for Their Importance in Human Disease

Overview

Journal Discov Immunol

Specialty Allergy & Immunology

Date 2024 Apr 3

PMID 38567057

Authors

Anna Veronika Hipp

Bertram Bengsch

Anna-Maria Globig

Affiliations

Soon will be listed here.

Abstract

The term refers to interleukin 17 (IL-17)-producing CD8 T cells. While IL-17 is an important mediator of mucosal defense, it is also centrally involved in driving the inflammatory response in immune-mediated diseases, such as psoriasis, multiple sclerosis, and inflammatory bowel disease. In this review, we aim to gather the current knowledge on the phenotypic and transcriptional profile, the and generation of Tc17 cells, and the evidence pointing towards a relevant role of Tc17 cells in human diseases such as infectious diseases, cancer, and immune-mediated diseases.

Citing Articles

Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronism.

Nowotny H, Zheng T, Seiter T, Ju J, Schneider H, Kroiss M Front Immunol. 2025; 15:1428054.

PMID: 39749333 PMC: 11693743. DOI: 10.3389/fimmu.2024.1428054.

Mouse CD8+ T cell subsets differentially generate IL-17-expressing cells in the colon epithelium and lamina propria.

Ge C, Tong Q, Zheng S, Liu L, Tian L, Luo H Clin Exp Immunol. 2025; 219(1).

PMID: 39745881 PMC: 11780888. DOI: 10.1093/cei/uxae120.

Adapting for success: T cell features at tissue sites.

Ahern P, Gwyer Findlay E Discov Immunol. 2024; 3(1):kyae009.

PMID: 38887634 PMC: 11180788. DOI: 10.1093/discim/kyae009.

References

Hamada H, Garcia-Hernandez M, Reome J, Misra S, Strutt T, McKinstry K . Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009; 182(6):3469-81. PMC: 2667713. DOI: 10.4049/jimmunol.0801814. View

Murata K, Inami M, Hasegawa A, Kubo S, Kimura M, Yamashita M . CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol. 2003; 15(8):987-92. DOI: 10.1093/intimm/dxg102. View

Simoni Y, Becht E, Fehlings M, Loh C, Koo S, Teng K . Bystander CD8 T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature. 2018; 557(7706):575-579. DOI: 10.1038/s41586-018-0130-2. View

Yang X, Ghoreschi K, Steward-Tharp S, Rodriguez-Canales J, Zhu J, Grainger J . Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol. 2011; 12(3):247-54. PMC: 3182404. DOI: 10.1038/ni.1995. View

Barber D, Wherry E, Masopust D, Zhu B, Allison J, Sharpe A . Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2005; 439(7077):682-7. DOI: 10.1038/nature04444. View

Bettelli E, Carrier Y, Gao W, Korn T, Strom T, Oukka M . Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441(7090):235-8. DOI: 10.1038/nature04753. View

Conti H, Shen F, Nayyar N, Stocum E, Sun J, Lindemann M . Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009; 206(2):299-311. PMC: 2646568. DOI: 10.1084/jem.20081463. View

Veldhoen M, Hocking R, Atkins C, Locksley R, Stockinger B . TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006; 24(2):179-89. DOI: 10.1016/j.immuni.2006.01.001. View

Nanjappa S, McDermott A, Fites J, Galles K, Wuthrich M, Deepe Jr G . Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cells. PLoS Pathog. 2017; 13(5):e1006356. PMC: 5456400. DOI: 10.1371/journal.ppat.1006356. View

10.

Wasiuk A, Testa J, Weidlick J, Sisson C, Vitale L, Widger J . CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy. J Immunol. 2017; 199(12):4110-4123. PMC: 5713498. DOI: 10.4049/jimmunol.1700606. View

11.

Liu S, Tsai J, Shen C, Sher Y, Hsieh C, Yeh Y . Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6. J Leukoc Biol. 2007; 82(2):354-60. DOI: 10.1189/jlb.0207111. View

12.

Chen K, Lin S, Zhou L, Xie H, Zhou W, Taki-Eldin A . Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis. PLoS One. 2011; 6(9):e24671. PMC: 3173477. DOI: 10.1371/journal.pone.0024671. View

13.

Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao R, Venkataraman R . T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab. PLoS One. 2017; 12(7):e0180088. PMC: 5495335. DOI: 10.1371/journal.pone.0180088. View

14.

Wolberg G, Zimmerman T, Hiemstra K, Winston M, Chu L . Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate. Science. 1975; 187(4180):957-9. DOI: 10.1126/science.167434. View

15.

Miossec P, Korn T, Kuchroo V . Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009; 361(9):888-98. DOI: 10.1056/NEJMra0707449. View

16.

Nestle F, Kaplan D, Barker J . Psoriasis. N Engl J Med. 2009; 361(5):496-509. DOI: 10.1056/NEJMra0804595. View

17.

Carter L, Fouser L, Jussif J, Fitz L, Deng B, Wood C . PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 2002; 32(3):634-43. DOI: 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9. View

18.

Moschen A, Tilg H, Raine T . IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting. Nat Rev Gastroenterol Hepatol. 2018; 16(3):185-196. DOI: 10.1038/s41575-018-0084-8. View

19.

Nanjappa S, Heninger E, Wuthrich M, Gasper D, Klein B . Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog. 2012; 8(7):e1002771. PMC: 3400565. DOI: 10.1371/journal.ppat.1002771. View

20.

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View